Propanc Biopharma, Inc.
PPCB
$1.87
-$0.08-4.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 247.95% | 56.99% | -55.92% | 240.32% | -91.35% |
| Total Receivables | 80.00% | -39.39% | 10.00% | -43.40% | 35.90% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 691,350.00% | -84.44% | 542.86% | 0.00% | -88.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 53,989.44% | -16.28% | -15.35% | 96.90% | -93.88% |
|
|
|||||
| Total Current Assets | 53,989.44% | -16.28% | -15.35% | 96.90% | -93.88% |
| Net Property, Plant & Equipment | -74.24% | -48.84% | -27.53% | -20.89% | -22.41% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23,584.44% | 84.93% | 0.34% | 1,355.00% | 0.00% |
| Total Assets | 28,597.32% | 23.43% | -12.15% | 94.10% | -84.58% |
|
|
|||||
| Total Accounts Payable | -8.30% | -1.24% | 2.09% | 2.16% | 2.59% |
| Total Accrued Expenses | 13.88% | -1.14% | 9.08% | 4.57% | 5.71% |
| Short-term Debt | 2.86% | 9.90% | 17.04% | 1.07% | -9.53% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -73.97% | -48.59% | -26.80% | -13.00% | -2.62% |
| Total Finance Division Other Current Liabilities | 20.55% | -3.63% | 0.92% | 3.94% | -36.86% |
| Total Other Current Liabilities | 20.55% | -3.63% | 0.92% | 3.94% | -36.86% |
| Total Current Liabilities | 4.48% | 1.31% | 8.13% | 2.84% | -1.97% |
|
|
|||||
| Total Current Liabilities | 4.48% | 1.31% | 8.13% | 2.84% | -1.97% |
| Long-Term Debt | 14.09% | 16.74% | 20.31% | 24.95% | 33.24% |
| Short-term Debt | 2.86% | 9.90% | 17.04% | 1.07% | -9.53% |
| Capital Leases | -- | -- | -- | -- | -76.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.67% | 1.57% | 8.32% | 3.06% | -1.80% |
|
|
|||||
| Common Stock & APIC | 123.38% | 0.09% | 0.20% | 0.57% | 0.48% |
| Retained Earnings | -80.12% | -0.64% | -0.53% | -0.54% | -0.82% |
| Treasury Stock & Other | -1.89% | 28.57% | -8.09% | -5.41% | 9.69% |
| Total Common Equity | 535.04% | -1.23% | -8.71% | -2.15% | -3.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 535.04% | -1.23% | -8.71% | -2.15% | -3.81% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 535.04% | -1.23% | -8.71% | -2.15% | -3.81% |
|
|
|||||